Sinusitis Drugs Market by Product, Disease Type, and Geography - Forecast and Analysis 2023-2027

Published: Nov 2022 Pages: 167 SKU: IRTNTR70260

The global sinusitis drugs market size is estimated to grow by USD 801.39 million between 2022 and 2027 accelerating at a CAGR of 6.23%. 

This sinusitis drugs market report extensively covers market segmentation by Product (steroid nasal sprays, antibiotics, decongestants, and other drugs) and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. 

Sinus infections are caused by trapped fluid in the sinus glands, which can lead to the growth of germs. The CDC reports that 9 out of 10 adults and 5-7 out of 10 children in the US get sinus infections from viruses. Bacterial infections are less common, affecting 1 out of 10 adults and 3-5 out of 10 children. Allergies, pollutants, and fungal infections can also cause sinus infections. Risk factors include respiratory tract infections, sinus gland structural problems, weakened immunity or immunosuppressive drugs, and nasal polyps. To help patients fight sinus infections market players are focussing on mergers and acquisitions strategy and at the same time they are increasing the awareness of this infection. 

Sinusitis Drugs Market Overview:

 View the Bestselling Market Research Sample 

Sinusitis Drugs Market Covid Recovery Analysis:

The COVID-19 pandemic had only a slight negative impact on the sinusitis drugs market in North America in 2020, despite affecting all countries, especially the US. Lockdowns and government guidelines led to limited or halted non-urgent treatments and clinical visits, causing a slight decline in sales of sinusitis drugs through offline medical stores. However, the use of e-commerce channels increased, leading to a rise in demand for sinusitis drugs online. Overall, the market witnessed a mixed impact in 2020 and Q1 2021. As pharmaceuticals were considered essential services, demand and supply were not significantly affected, and sinusitis drugs were made available through both online and offline channels. The availability of these drugs is expected to lead to market growth during the forecast period.

Sinusitis Drugs Market: Key Drivers, Trends, Challenges

 Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Sinusitis Drugs Market Driver

Vendors in the global sinusitis drugs market are increasingly engaging in mergers and acquisitions to develop novel therapies for the treatment of sinusitis. For example, Armata Pharmaceuticals completed a merger between C3J Therapeutics and AmpliPhi Biosciences to develop bacteriophage therapeutics to combat antibiotic resistance. Knopp Biosciences is collaborating with UK medical research companies to evaluate the efficacy of its lead drug candidate, dexpramipexole, for treating severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps. Such efforts are expected to boost drug development activities and create opportunities for other vendors to enter the market.

Significant Sinusitis Drugs Market Trends

Major players in the global sinusitis drugs market are investing heavily in R&D to develop new drugs for the treatment of sinusitis. LYRA THERAPEUTICS raised USD 29 million for its implant, LYR-210, which is designed using novel technologies to deliver approved steroids in the sinonasal tissues that are difficult to penetrate with traditional therapeutic options. LYR-210 is inserted into the inflamed sinonasal area, ensuring gradual release of topical steroids for six months. Phase I trials showed it was well-tolerated and effective in reducing chronic rhinosinusitis symptoms. The emergence of novel drug delivery systems and increased investments in R&D are expected to boost the consumption of sinusitis drugs and drive market growth.

Major Sinusitis Drugs Market Challenge

The lack of development of antibiotics to fight multidrug-resistant bacteria is a major challenge for the growth of the sinusitis drugs market. Most drugs in the pipeline are modifications of existing antibiotics, and sales of antibiotics have declined due to antibiotic resistance in sinusitis patients. Major vendors such as Bayer, Merck, Novartis, Sanofi, and Pfizer have stopped investing in antibiotic research and are exiting the market. Novartis sold its three antibiotics to Boston Pharmaceuticals, and Sanofi sold its antibiotic unit to Evotec. Developing new antibiotics is expensive and time-consuming, and the commercial potential and return on investment are low due to antibiotic resistance. Overuse of prescription antibiotics is the main cause of rising resistance, hindering the development of novel antibiotics. This lack of investment in antibiotics may cause a decline in the growth of the sinusitis drugs market during the forecast period.

Who are the Major Sinusitis Drugs Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbvie - The company offers sinusitis drugs such as RINVOQ (upadacitinib). Also, under this segment, the company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance globally to achieve its established long-term strategic goals.

The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market vendors, including:

  • Alembic Pharmaceuticals Ltd.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Bionpharma Inc.
  • CHIESI Farmaceutici SpA
  • Cipla Ltd.
  • Dr Reddys Laboratories Ltd.
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Neopharma Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teligent Inc.
  • Teva Pharmaceutical Industries Ltd.

Technavio’s report consists of a holistic analysis of the key development analysis,  development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.  

Sinusitis Drugs Market Segmentation by Product and Geography

Product  Analysis

The market share growth by the steroid nasal sprays segment will be significant during the forecast period. The high market share of this segment is attributed to the therapeutic efficacy of these drugs in relieving the signs and symptoms of sinusitis. Steroid nasal sprays are used as off-label prescription drugs. They act by reducing swelling and mucus production, thus relieving the symptoms of nasal congestion and improving the drainage of fluid from the sinus. However, these drugs do not provide immediate relief of symptoms and may require multiple administrations to yield the desired outcome. These drugs are often used in combination with nasal wash for better outcomes in patients with sinusitis and other nasal problems. Flonase, NASACORT AQ, Nasonex, Rhinocort, Zetonna, and QNASL are some of the steroid nasal sprays available in the market. Such factors are driving market growth.

Get a detailed analysis of various segments View Sample PDF 

Geographical Analysis

For more insights on the market share of various regions View PDF Sample now!

North America is projected to contribute 40% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market growth in this region is attributed to the increased investments in R&D by large pharmaceutical companies and the presence of a proper regulatory framework for the approval of new drugs in the region.  Also, Genentech is also engaged in conducting Phase II clinical trials on XOLAIR (omalizumab) for the treatment of nasal polyps. The successful launch of new drugs for these indications will result in a paradigm shift from small molecules to biologics and also pave the path for other vendors to enter the market, which contributes to market growth.

Sinusitis Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2022

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.23%

Market growth 2023-2027

USD 801.39 million

Market structure

Fragmented

YoY growth (%)

4.96

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key consumer countries

US, Germany, UK, France, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Ltd., Dr Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Merck and Co. Inc., Neopharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teligent Inc., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF sample

What are the Key Data Covered in this Sinusitis Drugs Market Report?

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will drive sinusitis drugs market growth during the next five years
  • Precise estimation of the sinusitis drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the sinusitis drugs market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of sinusitis drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global sinusitis drugs market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global sinusitis drugs market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Disease type Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Disease type Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Steroid nasal sprays - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
    • 6.4 Antibiotics - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
    • 6.5 Decongestants - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Decongestants - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Decongestants - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Decongestants - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Decongestants - Year-over-year growth 2022-2027 (%)
    • 6.6 Other drugs - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Other drugs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Other drugs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Other drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Other drugs - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Product
      • Exhibit 50: Market opportunity by Product ($ million)

    7 Market Segmentation by Disease Type

    • 7.1 Market segments
      • Exhibit 51: Chart on Disease Type - Market share 2022-2027 (%)
      • Exhibit 52: Data Table on Disease Type - Market share 2022-2027 (%)
    • 7.2 Comparison by Disease Type
      • Exhibit 53: Chart on Comparison by Disease Type
      • Exhibit 54: Data Table on Comparison by Disease Type
    • 7.3 Acute sinusitis - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Acute sinusitis - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Acute sinusitis - Year-over-year growth 2022-2027 (%)
    • 7.4 Chronic sinusitis - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
    • 7.5 Sub-acute sinusitis - Market size and forecast 2022-2027
      • Exhibit 63: Chart on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Disease Type
      • Exhibit 67: Market opportunity by Disease Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 71: Chart on Geographic comparison
      • Exhibit 72: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 France - Market size and forecast 2022-2027
      • Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 109: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 112: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 113: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 114: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 115: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 116: AbbVie Inc. - Overview
              • Exhibit 117: AbbVie Inc. - Product / Service
              • Exhibit 118: AbbVie Inc. - Key offerings
            • 12.4 Alembic Pharmaceuticals Ltd.
              • Exhibit 119: Alembic Pharmaceuticals Ltd. - Overview
              • Exhibit 120: Alembic Pharmaceuticals Ltd. - Product / Service
              • Exhibit 121: Alembic Pharmaceuticals Ltd. - Key offerings
            • 12.5 Bayer AG
              • Exhibit 122: Bayer AG - Overview
              • Exhibit 123: Bayer AG - Business segments
              • Exhibit 124: Bayer AG - Key offerings
              • Exhibit 125: Bayer AG - Segment focus
            • 12.6 Dr Reddys Laboratories Ltd.
              • Exhibit 126: Dr Reddys Laboratories Ltd. - Overview
              • Exhibit 127: Dr Reddys Laboratories Ltd. - Business segments
              • Exhibit 128: Dr Reddys Laboratories Ltd. - Key offerings
              • Exhibit 129: Dr Reddys Laboratories Ltd. - Segment focus
            • 12.7 Fresenius SE and Co. KGaA
              • Exhibit 130: Fresenius SE and Co. KGaA - Overview
              • Exhibit 131: Fresenius SE and Co. KGaA - Business segments
              • Exhibit 132: Fresenius SE and Co. KGaA - Key news
              • Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
              • Exhibit 134: Fresenius SE and Co. KGaA - Segment focus
            • 12.8 GlaxoSmithKline Plc
              • Exhibit 135: GlaxoSmithKline Plc - Overview
              • Exhibit 136: GlaxoSmithKline Plc - Business segments
              • Exhibit 137: GlaxoSmithKline Plc - Key offerings
              • Exhibit 138: GlaxoSmithKline Plc - Segment focus
            • 12.9 Hikma Pharmaceuticals Plc
              • Exhibit 139: Hikma Pharmaceuticals Plc - Overview
              • Exhibit 140: Hikma Pharmaceuticals Plc - Business segments
              • Exhibit 141: Hikma Pharmaceuticals Plc - Key offerings
              • Exhibit 142: Hikma Pharmaceuticals Plc - Segment focus
            • 12.10 Johnson and Johnson
              • Exhibit 143: Johnson and Johnson - Overview
              • Exhibit 144: Johnson and Johnson - Business segments
              • Exhibit 145: Johnson and Johnson - Key news
              • Exhibit 146: Johnson and Johnson - Key offerings
              • Exhibit 147: Johnson and Johnson - Segment focus
            • 12.11 Merck and Co. Inc.
              • Exhibit 148: Merck and Co. Inc. - Overview
              • Exhibit 149: Merck and Co. Inc. - Business segments
              • Exhibit 150: Merck and Co. Inc. - Key news
              • Exhibit 151: Merck and Co. Inc. - Key offerings
              • Exhibit 152: Merck and Co. Inc. - Segment focus
            • 12.12 Neopharma Corp.
              • Exhibit 153: Neopharma Corp. - Overview
              • Exhibit 154: Neopharma Corp. - Product / Service
              • Exhibit 155: Neopharma Corp. - Key news
              • Exhibit 156: Neopharma Corp. - Key offerings
            • 12.13 Novartis AG
              • Exhibit 157: Novartis AG - Overview
              • Exhibit 158: Novartis AG - Business segments
              • Exhibit 159: Novartis AG - Key offerings
              • Exhibit 160: Novartis AG - Segment focus
            • 12.14 Pfizer Inc.
              • Exhibit 161: Pfizer Inc. - Overview
              • Exhibit 162: Pfizer Inc. - Product / Service
              • Exhibit 163: Pfizer Inc. - Key news
              • Exhibit 164: Pfizer Inc. - Key offerings
            • 12.15 Sanofi SA
              • Exhibit 165: Sanofi SA - Overview
              • Exhibit 166: Sanofi SA - Business segments
              • Exhibit 167: Sanofi SA - Key news
              • Exhibit 168: Sanofi SA - Key offerings
              • Exhibit 169: Sanofi SA - Segment focus
            • 12.16 Sun Pharmaceutical Industries Ltd.
              • Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
            • 12.17 Teva Pharmaceutical Industries Ltd.
              • Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 178: Inclusions checklist
                • Exhibit 179: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 180: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 181: Research methodology
                • Exhibit 182: Validation techniques employed for market sizing
                • Exhibit 183: Information sources
              • 13.5 List of abbreviations
                • Exhibit 184: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              sinusitis drugs market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis